Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-11 · accession 0001415889-22-000507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-12 | 2022-01-11 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $1.00 | +18.8K | 94.6K | +25% | +$18.8K |
| D | 2022-01-12 | 2022-01-11 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $0.00 | -18.8K | 15.6K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | M | A | 18,750 | $1.00 | 94,571 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-11 | M | D | 18,750 | $0.00 | 15,625 | D | $1.00 · — to 2029-05-23 | 34,375 Common Stock | (F1) 25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter. |